Vistara Single-gene NIPT

Prenatal noninvasive test for single-gene screening
bt_bb_section_bottom_section_coverage_image

Vistara is the most comprehensive prenatal single-gene screening test for serious genetic conditions. These conditions, which affect quality of life, could benefit from early intervention and might otherwise go undetected.

Vistara> tests 25 serious genetic diseases, with a single blood sample taken from the mother. The results will be sent to the doctor in 2-3 weeks.

Vistara is the only NIPT that brings clinically relevant information about the health of the fetus.

https://i0.wp.com/amsgeneticlab.ro/wp-content/uploads/2022/02/Panorama-Vistara.png?fit=1080%2C573&ssl=1

Information obtained as early as possible during pregnancy leads to proper medical management.

Screen for 25 autosomal dominant and X-linked conditions across 30 genes with Vistara single-gene NIPT

  • Provide clinically actionable information:
    • Many single-gene conditions benefit from early intervention
    • Inform decisions for pregnancy and delivery management, early interventions, and patient education to ensure every child reaches their full potential
  • Perform testing with ease and get clear results
    • No paternal and/or egg-donor* sample necessary
    • Find conditions other screening modalities would miss until after the window for critical intervention

*if applicable

https://i0.wp.com/amsgeneticlab.ro/wp-content/uploads/2022/08/Incidence-at-birth-transp.png?fit=4500%2C3029&ssl=1

Vistara screens conditions with a combined incidence greater than Down syndrome1,2

All pregnancies can benefit from Vistara

Some scenarios where single-gene NIPT should be considered
https://i0.wp.com/amsgeneticlab.ro/wp-content/uploads/2021/12/VIS_couples_1-e1639594182402.jpg?resize=240%2C240&ssl=1

Couples with a male partner over 40-years-old

https://i0.wp.com/amsgeneticlab.ro/wp-content/uploads/2021/12/Vistara-ultrasound-scaled-e1639594573520_240x240.jpg?resize=240%2C240&ssl=1

Ultrasound anomalies including shortened long bones and increased nuchal translucency

https://i0.wp.com/amsgeneticlab.ro/wp-content/uploads/2021/12/Family-history-scaled-e1639594752226_240x240.jpg?resize=240%2C240&ssl=1

Family history of hereditary conditions

https://i0.wp.com/amsgeneticlab.ro/wp-content/uploads/2021/12/Vistara-informatii-scaled-e1639594910550-1.jpg?resize=240%2C240&ssl=1

Patients who want as much information as possible

No errors detected in clinical validation

Vistara’s clinical validation published in Nature Medicine (Zhang et al) showed the following performance metrics:2

  • >99% sensitivity
  • >99% specificity

Make confident pregnancy management and early intervention decisions with performance you can trust.

Vistara single-gene NIPT:

  • Has one of the most comprehensive Noonan panels available
  • Screens for conditions that are not included in standard diagnostic

References

1Snijders, et al. Ultrasound Obstet Gynecol 1999;13:167-170.

2Zhang J et al. Nat Med. 2019 Mar;25(3):439-447.

3Pagon RA et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2017.